Funded Biotech startups in New Jersey
Every company below filed a Form D with the SEC from a New Jersey address. Amounts are as reported on the filing, not estimates.
Updated Jul 31, 2026
- Companies
- 9
- Total raised
- $39.3M
- Filings
- 15
- Median round
- $1.0M
- Cities
- 8
CompanyCityLast filingLatest round
Hepion PharmaceuticalsBlood tests for early liver cancer detection
Red Bank
Jul 31, 2026
$3.1M
TETmedicalRapid blood test for ischemic stroke
Fair Haven
Jun 12, 2026
$3.5M
Optimeos Life SciencesNon-viral nanoparticles for delivering RNA and biologics
Princeton
May 22, 2026
$1.0M
SentrimedOral podoplanin inhibitor for head and neck cancer
Mullica Hill
May 8, 2026
$250K
Outlook TherapeuticsOphthalmic bevacizumab for wet macular degeneration
Iselin
Apr 23, 2026
N/A
Claris BiotherapeuticsEye drop biologic for neurotrophic keratitis
Jersey City
Sep 12, 2025
$2.3M
Cyclacel PharmaceuticalsCell cycle drugs for drug-resistant cancers
Berkeley Heights
Mar 21, 2025
$1.0M
Grace TherapeuticsIV treatment for a rare type of brain bleed
Princeton
Feb 10, 2025
$15.0M
IVIEW TherapeuticsEyelid wipe drug for dry eye disease
Cranbury
May 14, 2024
$9.2M
All 9 companies · most recent filing first
Most recent filings
9All 9 companies · most recent filing first